| Dr Narayana Menta Prasanna, MD | |
|
180 Academy St, Suite 1, Presque Isle, ME 04769-3145 | |
| (207) 760-8100 | |
| (207) 760-8188 |
| Full Name | Dr Narayana Menta Prasanna |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 180 Academy St, Presque Isle, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881666816 | NPI | - | NPPES |
| 109080000 | Medicaid | ME | |
| CH6750 | Other | ME | RAILROAD MEDICARE |
| 000418 | Other | ME | ANTHEM STAR ID |
| 287280099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 008959 (Maine) | Primary |
| 207YX0602X | Otolaryngology - Otolaryngic Allergy | 008959 (Maine) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Narayana Menta Prasanna, MD 180 Academy St, Suite 1, Presque Isle, ME 04769-3145 Ph: (207) 760-8100 | Dr Narayana Menta Prasanna, MD 180 Academy St, Suite 1, Presque Isle, ME 04769-3145 Ph: (207) 760-8100 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting glycolate oxidase for the treatment of primary hyperoxaluria type 1.
New research from the University of Minnesota Medical School found mutations in a novel gene that may help identify patients with a specific form of muscular dystrophy.
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) previews the key sessions ahead of its annual congress – a dedicated platform to promote and enhance research in Multiple Sclerosis. The 32nd edition of the world's largest congress of multiple sclerosis will take place in London from 14 – 17 September 2016.
Cegedim Dendrite, the world's leading provider of Life Sciences-specific customer relationship management (CRM) solutions, announced today that Boryung Pharmaceutical Co., Ltd., has implemented Cegedim Dendrite's Mobile Intelligence™ CRM solution. Boryung Pharmaceutical is one of Korea's top 10 domestic pharmaceutical companies, and Cegedim Dendrite currently serves 14 of the industry's top-grossing companies in Korea.
In 2008, physicians at Mayo Clinic Florida led by Herbert Wolfsen, M.D., were looking for new ways to keep in touch with the large group of esophageal cancer patients cared for by him and other gastroenterologists and surgeons. Telephone calls, faxes and email had worked to create a network of patients but many now wanted interactive and remote access capability to share their experiences and challenges with this serious disease.
› Verified 7 days ago